19.06.2013
- Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief...
29.07.2011
- Bristol-Myers Squibb reported Thursday a profit for the second quarter that declined from last year, hurt by higher restructuring and licensing charges. However, sales of company's...
